Tezepelumab for Atopic Diseases

Apr 10, 2020, 02:15 PM

Clinical investigator and allergist Jonathan Corren, MD, shares insight on the TSLP inhibitor.
Subscribe
Next
Comparing GLP-1 Receptor Agonists with SGLT2 Inhibitors for Type 2 Diabetes Patients
Top episodes